[Patient with haemolytic anemia and treatment with capecitabine. Review of one case and literature].
Maciá Escalante
S
S
Rodríguez Lescure
A
A
Martínez Banaclocha
N
N
Gallego Plazas
J
J
Carrato Mena
A
A
D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D005878:Gilbert Disease / Q000150:complications*; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D015412:Mastectomy, Segmental; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic
D003841:Deoxycytidine; D015251:Epirubicin; D000069287:Capecitabine; D003520:Cyclophosphamide; D005472:Fluorouracil